Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Biotech Sector Transcripts
Biotech Sector
Biotech Sector Main
Biotech Diagnosis
Biotech Equipment
Biotech Research
Biotech Transcripts
Latest
Most Popular
Wednesday, August 5th, 2009
XenoPort, Inc. Q2 2009 Earnings Call Transcript
•
XNPT
•
Comment!
Targacept, Inc. Q2 2009 Earnings Call Transcript
•
TRGT
•
Comment!
OraSure Technologies Inc., Q2 2009 Earnings Call Transcript
•
OSUR
•
Comment!
Thoratec Corp. Q2 2009 Earnings Call Transcript
•
THOR
•
Comment!
Shire plc Q2 2009 Earnings Call Transcript
•
SHPGY
•
Comment!
Tuesday, August 4th, 2009
Volcano Corporation Q2 2009 Earnings Call Transcript
•
VOLC
•
Comment!
Bio-Rad Laboratories, Inc. Q2 2009 Earnings Call Transcript
•
BIO
•
Comment!
Cephalon, Inc. Q2 2009 Earnings Call Transcript
•
CEPH
•
Comment!
Nektar Therapeutics Q2 2009 Earnings Call Transcript
•
NKTR
•
Comment!
Genomic Health, Inc. Q2 2009 Earnings Call Transcript
•
GHDX
•
Comment!
Monday, August 3rd, 2009
MannKind CorporationĀ Q2 2009 Earnings Call Transcript
•
MNKD
•
Comment!
Ligand Pharmaceuticals Inc. Q2 2009 Earnings Call Transcript
•
LGND
•
Comment!
Friday, July 31st, 2009
United Therapeutics Corp. Q2 2009 Earnings Call Transcript
•
UTHR
•
Comment!
Inspire Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript
•
ISPH
•
Comment!
Thursday, July 30th, 2009
DepoMed, Inc. Q2 2009 Earnings Call Transcript
•
DEPO
•
Comment!
BioMarin Pharmaceutical Inc. Q2 2009 Earnings Call Transcript
•
BMRN
•
Comment!
Exelixis, Inc. Q2 2009 Earnings Call Transcript
•
EXEL
•
Comment!
Spherion Corp. Q2 2009 Earnings Call Transcript
•
SFN
•
Comment!
Antigenics, Inc. Q2 2009 Earnings Call Transcript
•
AGEN
•
Comment!
To search across transcripts, find the most recent and most popular and view by sector, try:
Seeking Alpha's Transcript Center
Previous Page
1
...
5
6
7
8
...
58
Next Page
Most Popular Biotech Articles
My 10 Picks for 2010's Tech Revolution
It's Time for Adventrx to Follow Through on NDA
Good News for Vical Cancer Drug Candidate
Micromet's BiTE Pipeline Impresses
Adventrx Pharmaceuticals Gains Nearly 63%, Still Looking for More
Latest Biotech Articles
Micromet's BiTE Pipeline Impresses
Good News for Vical Cancer Drug Candidate
It's Time for Adventrx to Follow Through on NDA
Questcor Gets FDA Target Date for Epilepsy Drug
My 10 Picks for 2010's Tech Revolution